Boston Scientific Corporation (NYSE: BSX) announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial. The results found that percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(R) Paclitaxel-Eluting Coronary Stent System was consistently associated with fewer patient hospital days during the first year after treatment compared to coronary artery bypass graft (CABG) surgery.
Lees meer..

Executive vice president is pharmaceutical industry veteran Arthur Simon, Ph.D. Though new in name, Palm Beach CRO - a clinical research organization recently formed in West Palm Beach, Florida - is headed by a veteran pharmacologist and clinical research executive: Arthur Simon, Ph.D.
Lees meer..

Miltenyi Biotec announces the worldwide and exclusive release of Myelin Removal Beads. Myelin is a specialized membrane which ensheathes and insulates axons in the peripheral and central nervous system. During preparation of single-cell suspensions, myelin membrane fragments represent the major contaminant. “When dissociating adult neural tissue, usually less than 5 percent of the cell suspension consists of cells. The rest corresponds to cell debris”, explains Dr.
Lees meer..

In a first of its kind study, Scientific American cut through the marketing messages to take a hard look at what countries across the globe are doing to bolster biotech programs within their borders. Many rankings compare Europe, Asia, and the US — the Scientific American Worldview: A Global Biotechnology Perspective digs deeper, examining all the elements that impact overall biotech innovation. You might be surprised by some of the results.
Lees meer..

Invetech, specialists in product development and custom automation for the medical, industrial and consumer markets, announced that TearLab Corporation’s revolutionary TearLab Osmolarity System has been recognised for its innovative design with a prestigious Medical Design Excellence Award (MDEA). TearLab Corporation retained Invetech to assist with the development and industrial design of its instrumentation.
Lees meer..

Quotient Bioresearch Limited (”Quotient”), a leading provider of drug development services, announces that it has acquired Charles River Laboratories’ (Charles River) Edinburgh clinical research facility. This represents the sixth acquisition in approximately three years for Quotient.
Lees meer..

EFPIA, the voice of the pharmaceutical industry in Europe, of which the Irish Pharmaceutical Healthcare Association (IPHA) is a member, has announced an important step in the industry’s efforts to protect Europe’s citizens against counterfeit medicines. EFPIA has agreed to run a pilot of its coding and identification solution (1) in Sweden later this year in partnership with Swedish retail pharmacy chain Apoteket AB and local wholesalers Tamro and KD.
Lees meer..

The board of directors of Medtronic, Inc. (NYSE: MDT), announced that the company’s annual meeting of shareholders will be held at 10:30 a.m., Central Daylight Time, on Thursday, August 27, 2009 at Medtronic World Headquarters, located at 710 Medtronic Parkway, Minneapolis, Minnesota. Shareholders of record at the close of business on June 29, 2009, will be eligible to vote at the meeting.
Lees meer..

The U.S. Department of Justice and 16 states have joined two whistle-blower lawsuits filed in federal District Court in Massachusetts alleging that Wyeth defrauded the government by not offering the same discounts on two medications to Medicaid that it offered to hospitals, the
Lees meer..

UCSF scientists have created a method of quickly identifying large numbers of the genetic material known as short hairpin RNA - also called shRNA - that turns genes on and off.
Lees meer..